Simarro, J.; Pérez-Simó, G.; Mancheño, N.; Ansotegui, E.; Muñoz-Núñez, C.F.; Gómez-Codina, J.; Juan, Ó.; Palanca, S.
Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital. Cancers 2023, 15, 1705.
https://doi.org/10.3390/cancers15061705
AMA Style
Simarro J, Pérez-Simó G, Mancheño N, Ansotegui E, Muñoz-Núñez CF, Gómez-Codina J, Juan Ó, Palanca S.
Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital. Cancers. 2023; 15(6):1705.
https://doi.org/10.3390/cancers15061705
Chicago/Turabian Style
Simarro, Javier, Gema Pérez-Simó, Nuria Mancheño, Emilio Ansotegui, Carlos Francisco Muñoz-Núñez, José Gómez-Codina, Óscar Juan, and Sarai Palanca.
2023. "Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital" Cancers 15, no. 6: 1705.
https://doi.org/10.3390/cancers15061705
APA Style
Simarro, J., Pérez-Simó, G., Mancheño, N., Ansotegui, E., Muñoz-Núñez, C. F., Gómez-Codina, J., Juan, Ó., & Palanca, S.
(2023). Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital. Cancers, 15(6), 1705.
https://doi.org/10.3390/cancers15061705